These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 27238364)

  • 1. Repositioning the Old Fungicide Ciclopirox for New Medical Uses.
    Shen T; Huang S
    Curr Pharm Des; 2016; 22(28):4443-50. PubMed ID: 27238364
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reposition of the Fungicide Ciclopirox for Cancer Treatment.
    Huang Z; Huang S
    Recent Pat Anticancer Drug Discov; 2021; 16(2):122-135. PubMed ID: 33573561
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chelation of intracellular iron with the antifungal agent ciclopirox olamine induces cell death in leukemia and myeloma cells.
    Eberhard Y; McDermott SP; Wang X; Gronda M; Venugopal A; Wood TE; Hurren R; Datti A; Batey RA; Wrana J; Antholine WE; Dick JE; Schimmer AD
    Blood; 2009 Oct; 114(14):3064-73. PubMed ID: 19589922
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The antimycotic ciclopirox olamine induces HIF-1alpha stability, VEGF expression, and angiogenesis.
    Linden T; Katschinski DM; Eckhardt K; Scheid A; Pagel H; Wenger RH
    FASEB J; 2003 Apr; 17(6):761-3. PubMed ID: 12594177
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of HIV-1 gene expression by Ciclopirox and Deferiprone, drugs that prevent hypusination of eukaryotic initiation factor 5A.
    Hoque M; Hanauske-Abel HM; Palumbo P; Saxena D; D'Alliessi Gandolfi D; Park MH; Pe'ery T; Mathews MB
    Retrovirology; 2009 Oct; 6():90. PubMed ID: 19825182
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The fungicide ciclopirox inhibits lymphatic endothelial cell tube formation by suppressing VEGFR-3-mediated ERK signaling pathway.
    Luo Y; Zhou H; Liu L; Shen T; Chen W; Xu B; Han X; Zhang F; Scott RS; Alexander JS; Alam A; Huang S
    Oncogene; 2011 May; 30(18):2098-107. PubMed ID: 21217783
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ciclopirox olamine inhibits mTORC1 signaling by activation of AMPK.
    Zhou H; Shang C; Wang M; Shen T; Kong L; Yu C; Ye Z; Luo Y; Liu L; Li Y; Huang S
    Biochem Pharmacol; 2016 Sep; 116():39-50. PubMed ID: 27396756
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ciclopirox induces autophagy through reactive oxygen species-mediated activation of JNK signaling pathway.
    Zhou H; Shen T; Shang C; Luo Y; Liu L; Yan J; Li Y; Huang S
    Oncotarget; 2014 Oct; 5(20):10140-50. PubMed ID: 25294812
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The repositioning of the anti-fungal agent ciclopirox olamine as a novel therapeutic agent for the treatment of haematologic malignancy.
    Weir SJ; Patton L; Castle K; Rajewski L; Kasper J; Schimmer AD
    J Clin Pharm Ther; 2011 Apr; 36(2):128-34. PubMed ID: 21366640
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antileukemia Effect of Ciclopirox Olamine Is Mediated by Downregulation of Intracellular Ferritin and Inhibition β-Catenin-c-Myc Signaling Pathway in Glucocorticoid Resistant T-ALL Cell Lines.
    Wu J; Liu H; Zhang G; Gu L; Zhang Y; Gao J; Wei Y; Ma Z
    PLoS One; 2016; 11(8):e0161509. PubMed ID: 27551974
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Blocking eIF5A modification in cervical cancer cells alters the expression of cancer-related genes and suppresses cell proliferation.
    Mémin E; Hoque M; Jain MR; Heller DS; Li H; Cracchiolo B; Hanauske-Abel HM; Pe'ery T; Mathews MB
    Cancer Res; 2014 Jan; 74(2):552-62. PubMed ID: 24220243
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel mTOR inhibitory activity of ciclopirox enhances parthenolide antileukemia activity.
    Sen S; Hassane DC; Corbett C; Becker MW; Jordan CT; Guzman ML
    Exp Hematol; 2013 Sep; 41(9):799-807.e4. PubMed ID: 23660068
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting deoxyhypusine hydroxylase activity impairs cap-independent translation initiation driven by the 5'untranslated region of the HIV-1, HTLV-1, and MMTV mRNAs.
    Cáceres CJ; Angulo J; Contreras N; Pino K; Vera-Otarola J; López-Lastra M
    Antiviral Res; 2016 Oct; 134():192-206. PubMed ID: 27633452
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The antifungal drug ciclopirox inhibits deoxyhypusine and proline hydroxylation, endothelial cell growth and angiogenesis in vitro.
    Clement PM; Hanauske-Abel HM; Wolff EC; Kleinman HK; Park MH
    Int J Cancer; 2002 Aug; 100(4):491-8. PubMed ID: 12115536
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The antitumor activity of the fungicide ciclopirox.
    Zhou H; Shen T; Luo Y; Liu L; Chen W; Xu B; Han X; Pang J; Rivera CA; Huang S
    Int J Cancer; 2010 Nov; 127(10):2467-77. PubMed ID: 20225320
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ciclopirox enhances pancreatic islet health by modulating the unfolded protein response in diabetes.
    Mihailidou C; Chatzistamou I; Papavassiliou AG; Kiaris H
    Pflugers Arch; 2016 Nov; 468(11-12):1957-1968. PubMed ID: 27757583
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of hypoxia and intracellular iron chelation on hypoxia-inducible factor-1alpha and -1beta in the rat carotid body and glomus cells.
    Baby SM; Roy A; Mokashi AM; Lahiri S
    Histochem Cell Biol; 2003 Nov; 120(5):343-52. PubMed ID: 14600837
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oxygen accessibility and iron levels are critical factors for the antifungal action of ciclopirox against Candida albicans.
    Sigle HC; Thewes S; Niewerth M; Korting HC; Schäfer-Korting M; Hube B
    J Antimicrob Chemother; 2005 May; 55(5):663-73. PubMed ID: 15790671
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ciclopirox Inhibition of eIF5A Hypusination Attenuates Fibroblast Activation and Cardiac Fibrosis.
    Subbaiah KCV; Wu J; Tang WHW; Yao P
    J Cardiovasc Dev Dis; 2023 Jan; 10(2):. PubMed ID: 36826549
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro model of infected stratum corneum for the efficacy evaluation of poloxamer 407-based formulations of ciclopirox olamine against Trichophyton rubrum as well as differential scanning calorimetry and stability studies.
    Täuber A; Müller-Goymann CC
    Int J Pharm; 2015 Oct; 494(1):304-11. PubMed ID: 26276254
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.